ClinicalTrials.gov
public full text
Public Domain
FBnTP Imaging of Breast Cancer
Our preclinical studies suggest the capacity of the positron emission tomography imaging agent 18F-fluorobenzyl triphenyl phosphonium (FBnTP) to detects early-stage small breast tumors (e.g., DCIS), and differentiates benign from malignant masses with better accuracy than that obtained by existing breast imaging tools.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)#881853
- Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT#1309269
- Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities#1139057
- Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS#880462
- Characterizing Breast Cancer With 18F-FES PET/CT#863733
Record · ID 1195057
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive